170 related articles for article (PubMed ID: 31015316)
1. Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric Cancer.
Shin SJ; Park S; Kim MH; Nam CM; Kim H; Choi YY; Jung MK; Choi HJ; Rha SY; Chung HC
Oncologist; 2019 Nov; 24(11):e1108-e1114. PubMed ID: 31015316
[TBL] [Abstract][Full Text] [Related]
2. Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.
Yoo C; Ryu MH; Park YS; Yoo MW; Park SR; Ryoo BY; Jang SJ; Yook JH; Kim BS; Kang YK
Ann Surg Oncol; 2015 Sep; 22(9):2940-7. PubMed ID: 25605515
[TBL] [Abstract][Full Text] [Related]
3. Mesothelin expression correlates with prolonged patient survival in gastric cancer.
Baba K; Ishigami S; Arigami T; Uenosono Y; Okumura H; Matsumoto M; Kurahara H; Uchikado Y; Kita Y; Kijima Y; Kitazono M; Shinchi H; Ueno S; Natsugoe S
J Surg Oncol; 2012 Feb; 105(2):195-9. PubMed ID: 21780126
[TBL] [Abstract][Full Text] [Related]
4. Luminal membrane expression of mesothelin is a prominent poor prognostic factor for gastric cancer.
Einama T; Homma S; Kamachi H; Kawamata F; Takahashi K; Takahashi N; Taniguchi M; Kamiyama T; Furukawa H; Matsuno Y; Tanaka S; Nishihara H; Taketomi A; Todo S
Br J Cancer; 2012 Jun; 107(1):137-42. PubMed ID: 22644300
[TBL] [Abstract][Full Text] [Related]
5. Tissue
Sasahara M; Kanda M; Shimizu D; Tanaka C; Inokawa Y; Hattori N; Hayashi M; Nakayama G; Kodera Y
Anticancer Res; 2021 Feb; 41(2):609-617. PubMed ID: 33517265
[TBL] [Abstract][Full Text] [Related]
6. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
7. Mesothelin expression and its prognostic role according to microsatellite instability status in colorectal adenocarcinoma.
Kim H; Chung Y; Paik SS; Jang K; Shin SJ
Medicine (Baltimore); 2019 Jun; 98(26):e16207. PubMed ID: 31261569
[TBL] [Abstract][Full Text] [Related]
8. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
[TBL] [Abstract][Full Text] [Related]
9. Signet ring cell histology is an independent predictor of poor prognosis in gastric adenocarcinoma regardless of tumoral clinical presentation.
Piessen G; Messager M; Leteurtre E; Jean-Pierre T; Mariette C
Ann Surg; 2009 Dec; 250(6):878-87. PubMed ID: 19855261
[TBL] [Abstract][Full Text] [Related]
10. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
11. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer.
Sawaki K; Kanda M; Miwa T; Umeda S; Tanaka H; Tanaka C; Kobayashi D; Suenaga M; Hattori N; Hayashi M; Yamada S; Nakayama G; Fujiwara M; Kodera Y
Ann Surg Oncol; 2018 Jul; 25(7):2083-2090. PubMed ID: 29663169
[TBL] [Abstract][Full Text] [Related]
12. Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis.
Noda S; Yashiro M; Toyokawa T; Morimoto J; Shinto O; Muguruma K; Sawada T; Hirakawa K
Ann Surg Oncol; 2011 Dec; 18(13):3718-25. PubMed ID: 21573834
[TBL] [Abstract][Full Text] [Related]
13. C-C motif chemokine 22 ligand (CCL22) concentrations in sera of gastric cancer patients are related to peritoneal metastasis and predict recurrence within one year after radical gastrectomy.
Wei Y; Wang T; Song H; Tian L; Lyu G; Zhao L; Xue Y
J Surg Res; 2017 May; 211():266-278. PubMed ID: 28501127
[TBL] [Abstract][Full Text] [Related]
14. High CD8/CD33 ratio in peritoneal metastatic lesions is associated with favorable prognosis in gastric cancer.
Yamaguchi T; Kinoshita J; Saito H; Shimada M; Terai S; Moriyama H; Okamoto K; Makino I; Nakamura K; Tajima H; Ninomiya I; Fushida S
Cancer Rep (Hoboken); 2021 Oct; 4(5):e1389. PubMed ID: 33793095
[TBL] [Abstract][Full Text] [Related]
15. VEGF significance in peritoneal recurrence from gastric cancer.
Aoyagi K; Kouhuji K; Yano S; Miyagi M; Imaizumi T; Takeda J; Shirouzu K
Gastric Cancer; 2005; 8(3):155-63. PubMed ID: 16086118
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of mesothelin expression in peritoneal disease from colorectal and appendiceal cancers.
Yoon DH; Ibrahim A; Tatishchev S; Duldulao MPN; Lee SW; Shin J
J Surg Oncol; 2021 Dec; 124(7):1091-1097. PubMed ID: 34310720
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of extended biologic staging by bone marrow micrometastases and tumor-associated proteases in gastric cancer.
Heiss MM; Allgayer H; Gruetzner KU; Babic R; Jauch KW; Schildberg FW
Ann Surg; 1997 Dec; 226(6):736-44; discussion 744-5. PubMed ID: 9409572
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.
Lee KE; Lee HJ; Kim YH; Yu HJ; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Jpn J Clin Oncol; 2003 Apr; 33(4):173-9. PubMed ID: 12810831
[TBL] [Abstract][Full Text] [Related]
19. Examination of cancer cells exposed to gastric serosa by serosal stamp cytology plus RT-PCR is useful for the identification of gastric cancer patients at high risk of peritoneal recurrence.
Miki Y; Yashiro M; Ando K; Okuno T; Kitayama K; Masuda G; Tamura T; Sakurai K; Toyokawa T; Kubo N; Tanaka H; Muguruma K; Osawa M; Hirakawa K; Ohira M
Surg Oncol; 2017 Dec; 26(4):352-358. PubMed ID: 29113652
[TBL] [Abstract][Full Text] [Related]
20. Reduced preoperative serum albumin and absence of peritoneal dissemination may be predictive factors for long-term survival with advanced gastric cancer with positive cytology test.
Yamashita K; Ushiku H; Katada N; Hosoda K; Moriya H; Mieno H; Kikuchi S; Hoshi K; Watanabe M
Eur J Surg Oncol; 2015 Oct; 41(10):1324-32. PubMed ID: 26251341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]